Related Experiment Video

Updated: Aug 7, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Eukaryotic expression vectors and immunoconjugates for cancer therapy

E M Glinka1, E F Edelweiss, S M Deyev

  • 1Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997, Russia. em_glinka@mail.ru

Biochemistry. Biokhimiia
|July 11, 2006
PubMed

Insights

This review explores enhancing targeted anticancer therapies. Strategies include using tumor-specific promoters and antibody fusion proteins for improved specificity and efficacy in cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy
  • Immunotherapy

Background:

  • Targeted anticancer agents require high specificity to minimize off-target effects and maximize therapeutic efficacy.
  • Current strategies for enhancing specificity include transcriptional targeting and antibody-based approaches.

Purpose of the Study:

  • To review and analyze strategies for improving the specificity of targeted anticancer therapies.
  • To discuss the integration of gene therapy and antibody therapy for novel antitumor treatment approaches.

Main Methods:

  • Analysis of transcriptional activation using tissue- and tumor-specific promoters in eukaryotic expression vectors.
  • Review of antitumor-directed immunoconjugates, focusing on antibody fusion proteins.
  • Examination of vector design for encoding secreted forms of immunoconjugates.

Main Results:

  • Identification of strategies for selecting targeted promoters that enhance specificity.
  • Examples of antibody fusion proteins demonstrating significant antitumor activity.
  • Development of vectors enabling intracellular synthesis and secretion of targeted immunoconjugates.

Conclusions:

  • Combining gene therapy and antibody therapy offers a promising new direction for antitumor treatment.
  • Engineered vectors encoding secreted immunoconjugates can lead to sustained, targeted therapeutic agent delivery.
  • Enhanced specificity in targeted anticancer agents is achievable through advanced molecular and immunological strategies.

More Related Videos

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...